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Abstract
Introduction: Chronic Obstructive Pulmonary Disease (COPD) is one of the most common chronic diseases of adults and is a ma-
jor cause of chronic morbidity and mortality throughout the world. It is the cause of physical and mental suffering for the patient, 
significantly impairs quality of life, reduces the vital activity and affects the patient’s life in its various aspects.
In 2012, the nationwide survey was conducted in COPD outpatients with a history of smoking exploring the various factors of the 
disease and its effects on the health and life of the patient. The purpose of the analysis presented here is to assess the impact of 
COPD and tobacco smoking on the patient’s health and life.
Material and methods: Data were collected from patients by their physicians during routine visit with usage of specifically pre-
pared questionnaire for this study. Patients over 35 years of age, with diagnosed COPD, current or past smokers were recruited 
from outpatients settings. The study involved 10,365 patients with COPD. Representative sample of 2,967 questionnaires were 
randomly drawn for the statistical analysis. 
Results: The mean age of responders was 61.15 ± 10.25 years, 33.98% of participants were women, 56.73% were current 
smokers and 43.37% declared smoking in the past. The largest number of patients had COPD in a moderate degree (II — acc. to 
GOLD 2010) — 55.38%, sequentially mild (I) — 21.40%, and severe (III) — 19.96%, the smallest group were people with very 
severe degree of disease (IV) — 3.27%. Using the new classification of the COPD severity (acc. to GOLD 2013), the largest group 
of patients were less symptomatic (mMRC ) subjects who had a low risk (A) — 52.67%, but in fact a second group of patients 
were subjects with severe symptoms and a high risk (D) — 20 45% , sequentially — patients with low severity of symptoms, but 
a high risk (C) — 16.16% , and severe symptoms and a low risk — 10.72% (B). Patients most often reported that COPD affects 
their activity in sport (83.45% of respondents), than in living activity (82.78%) and family life (79.3%). COPD had significant (mo-
derate or severe) effect on sport (60.85%) and life activity (38.44%), as well as on work (34.9%), but the greatest impact, leading 
up to the resignation of the activity: on sport practice (21.75%), sexual intercourse (12.6%) and hobbies (11.49%). The disease 
severity (GOLD 2013 C/D) was the independent factor which reduced all forms of activity.
In patients’ opinion smoking had negative impact on their health (52,65%) and the family budget (41.83%). The negative impact of 
smoking on family relations was declared by 16.38% of respondents. Among the factors which favor effective quit from addiction 
were: age ≥ 65 years and more seere degree of obturation (III/IV GOLD 2010).
Conclusions: The results of the study confirmed the significant impact of the disease and addiction to smoking not only on 
patients’ life but also on their families.
Key words: COPD severity, GOLD, tobacco addiction, patients’ vital activity, family
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Streszczenie
Wstęp: Przewlekła obturacyjna choroba płuc (POChP) należy do najczęstszych chorób przewlekłych osób dorosłych i  jest jedną 
z głównych przyczyn przewlekłej chorobowości i umieralności na całym świecie. Dla chorego jest przyczyną fizycznego i psychiczne-
go cierpienia, znacznie upośledza jakość życia, ogranicza aktywność życiową i wpływa na życie chorego w różnych jego aspektach.
W 2012 roku przeprowadzono ogólnopolskie badanie ankietowe chorych na POChP z wywiadem palenia tytoniu leczonych am-
bulatoryjnie badające różne uwarunkowania choroby i jej skutki dla zdrowia i życia chorego. Celem przedstawionej tu analizy jest 
ocena wpływu POChP oraz nałogu palenia tytoniu na życie chorego i jego rodziny w Polsce.
Materiał i metody: Materiał stanowią dane zebrane od pacjentów przez ich lekarzy prowadzących, w trakcie jednej z rytuno-
wych wizyt chorego w poradni, na podstawie jednolitego, przygotowanego specjalnie dla potrzeb tego badania kwestionariusza. 
Do badania obserwacyjnego włączano pacjentów powyżej 35. rż. z rozpoznaną POChP, leczonych ambulatoryjnie, aktualnie lub 
w przeszłości palących tytoń.
W badaniu wzięło udział 10 365 chorych na POChP. Do analizy pobrano reprezentatywną próbę 2967 ankiet. 
Wyniki: Średnia wieku chorych wyniosła 61,15 ± 10,25 roku, kobiety stanowiły 33,98%. Aktualnych palaczy wśród uczestników 
badania było 56,73%, 43,37% deklarowało, że już nie pali tytoniu. W badanej grupie największą liczbę chorych stanowiły osoby 
ze stopniem umiarkowanym POChP (II) wg GOLD 2010 — 55,38%, kolejno łagodnym (I) — 21,40% i ciężkim (III) — 19,96%, 
najmniej liczną grupę stanowiły osoby ze stopniem bardzo ciężkim (IV) — 3,27%. Stosując klasyfikację ciężkości POChP według 
GOLD 2013, najliczniejszą grupę chorych stanowili niskoobjawowi (mMRC), o niskim stopniu ryzyka (A) — 52,67%, ale drugą 
w kolejności grupą byli chorzy z nasilonymi objawami i wysokim ryzykiem (D) — 20,45%, kolejno, chorzy z małym nasileniem 
objawów, ale wysokim ryzykiem (C) — 16,16% i z nasilonymi objawami i wysokim ryzykiem — 10,72% (B). Pacjenci najczęściej 
podawali, że POChP ma wpływ na uprawianie przez nich sportu (83,45% ankietowanych), codzienną aktywność życiową (82,78%) 
i życie rodzinne (79,3%). Istotny wpływ (znaczny lub duży) miała, prócz sportu (60,85%) i aktywności życiowej (38,44%), na życie 
zawodowe (34,9%), ale największy wpływ, prowadzący nawet do rezygnacji z aktywności, poza uprawianiem sportu (21,75%) 
miała na życie intymne (12,6%) i hobby (11,49%). Czynnikiem, który decydował o ograniczeniu wszystkich form aktywności, był 
stopień ciężkości w skali GOLD 2013 C/D. 
Według pacjentów palenie przez nich tytoniu miało negatywny wpływ najbardziej na ich zdrowie (52,65%) i budżet rodzinny 
(41,83%). Negatywny wpływ palenia na relacje rodzinne deklarowało 16,38% respondentów. Wśród czynników sprzyjających 
skutecznemu zerwaniu z nałogiem należy wymienić wiek ≥ 65. rż. i cięższy stopień obturacji (III/IV wg GOLD 2010).
Wnioski: Przeprowadzenie niniejszego badania obserwacyjnego potwierdziło istotny wpływ samej choroby oraz nałogu palenia 
tytoniu na życie pacjentów i ich rodzin.
Słowa kluczowe: ciężkość POChP, GOLD, uzależnienie od nikotyny, aktywność życiowa chorego, rodzina
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Introduction
Chronic obstructive pulmonary disease 
(COPD) is one of the most frequent chronic dise-
ases that affect adults, and it is one of the main 
causes of morbidity and mortality in the world. 
According to the World Health Organisation, 
currently more than 210 million people suffer from 
COPD in the world, including 80 million afflicted 
by its moderate or severe form [1]. In Poland, 
COPD is the second chronic disease in respect of 
prevalence. It affects every tenth person over 30 
years of age, and the total number of COPD pa-
tients is estimated at more than 2 million people 
[2]. The disease is the fourth cause of deaths in 
the world — 3 million people die from it every 
year; in Poland this number amounts to 15,000 
people, and it is still growing.
The costs of care of COPD patients in the 
EU are high, amounting to 38.6 billion EUR 
annually, which constitutes 56% of the budget 
allotted to diseases of the respiratory system. This 
is connected with the scale of the problem, the 
long-standing course of the disease and the degree 
of COPD severity. In the United States, the direct 
costs of medical care of COPD patients, including 
ambulatory care, drugs and particularly the costs 
of exacerbations and hospitalisations amount to 
29.5 billion dollars per year, and indirect costs 
connected with reduced work output, absence 
due to the disease, disability or premature death 
stand at 20.4 billion dollars. 
The disease causes physical and mental suf-
fering, it impairs patients’ quality of life, limits 
their functions within the family, as well as in-
fluencing the functioning of the whole family. On 
the other hand, a lack of support from the family 
results in mental disorders and worse effects of 
the therapy. Therefore, family problems should 
not be ignored in integrated therapy as they may 
be vital for efficacy of treatment. However, the 
influence of the disease on family life in Polish 
patients is not known due to a  lack of studies 
concerning this issue.
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The sudden increase in the incidence of 
the disease in recent decades has been caused 
by the increased number of people addicted to 
tobacco smoking, which together with longer life 
expectancy is the main cause of the disease and 
its progression in developed countries [3]. It is 
estimated that currently there are 1.1 billion smo-
kers in the world. Available data concerning the 
situation in Poland come from the study conduc-
ted by Professor Niżankowska-Mogilnicka and 
her team [4] in 2005 in the Małopolska region. 
The study was a part of the international BOLD 
study into the epidemiology of COPD. In the ge-
neral population there were 29.1% of people over 
40 years of age who were current smokers, with 
a predominance of men (frequency of smoking 
among men was 36.1%, among women it was 
21.9%), and nicotine dependence in the past was 
reported by 32.3% of respondents (42.9% of men 
and 21.5% of women).
The only effective way to reduce the risk of 
COPD and slow its progression on a global scale 
is smoking cessation [3]. The struggle with ad-
diction is difficult, and its effectiveness depends 
on many mental, biological and social factors, 
including motivation, degree of nicotine addic-
tion, mental and behavioural disorders such as 
depression and neuroses, as well as the attitude 
of the family and the social environment in which 
the smoker lives [5, 6]. There are many research 
projects into the evaluation of the efficacy of phar-
macological and non-pharmacological methods 
of smoking cessation [3], in Poland also [7–9], 
but they are missing information on the role of 
family in the process.
In 2012, a nationwide survey was conducted 
in COPD outpatients with a history of smoking, 
exploring demographical and clinical characte-
ristics and evaluating knowledge and attitude of 
the patients towards the disease, the therapy and 
nicotine addiction. 
The objective of the present paper was to 
evaluate the impact of COPD and tobacco smoking 
on the patient’s and his/her family life.
Material and methods
It was a cross-sectional, observational, non
-interventional, multi-centre and nationwide stu-
dy. It was conducted at the centres of outpatient 
primary health care (53.68% of respondents) and 
specialised centres of lung and allergic diseases 
(46.32% of respondents). 
Data were collected from patients by physi-
cians during routine visits at the centre, based 
on a uniform questionnaire that was prepared 
specially for the study. The questions were 
closed-ended, but in a few cases there was the 
possibility of giving another answer, if the cor-
rect one was not included in the questionnaire.
The observational study included patients 
who met the following criteria:
 — over 35 years of age, 
 — diagnosed COPD,
 — current or past tobacco smoker,
 — outpatient.
The questionnaires were completed between 
02.01.2012 and 31.04.2012. 
A total of 688 physicians and 10,365 COPD 
outpatients participated in the study. Statistical 
analysis was conducted on 2967 randomised 
questionnaires. It was calculated that the analy-
sis of 2401 questionnaires provides data with 
a probability of 0.95, with a maximum standard 
error of estimate 2%. The collected data were 
statistically analysed using the statistical software 
STATISTICA PL 10.0 and SPSS 21. For measura-
ble variables, basic descriptive characteristics 
were given, and for qualitative variables — pro-
portions compared to the number of available 
observations. Normality was tested using the 
Shapiro-Wilk test. To compare two independent 
groups, on account of quantitative variables, 
non-parametric Mann-Whitney U test was used 
(due to lack of normality of distribution of the 
examined variables). To examine the correlation 
between two qualitative variables, chi-squared 
test was used. To analyse correlation between 
two variables measured on the ordinal scale, the 
Spearman’s rank correlation coefficient was used. 
To identify independent risk factors of chosen 
events (poor evaluation of health condition, poor 
efficacy of drugs, the impact of the disease and 
tobacco smoking on the patient and his/her family 
life) models of logistic regression with the Wald 
forward selection were used. The results with P 
< 0.05 were considered as statistically significant.
Demographic data
The mean age (± standard deviation) in the 
study group was 61.15 ± 10.25 years. Women 
constituted 33.98% of the group and were ap-
proximately one year younger than men. Among 
the survey participants, there were 56.73% of 
current smokers, and 43.37% of respondents dec-
lared that they had stopped smoking. Generally, 
men smoked more cigarettes per day, and they 
had more pack years in their history, irrespec-
tive of smoking status. Detailed differences in 
demographic data between men and women are 
presented in Table 1.
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Results
History of the disease
The respondents usually declared that the di-
sease had been diagnosed from 2 to 5 years earlier 
(28.71% of respondents), whereas women repor-
ted a shorter history of the disease (P = 0.0024). 
Diagnosis was usually given by specialists of lung 
diseases (72.18%), followed by general practitio-
ners (24.32%) and other specialists.
Frequent (3-7 days per week) occurrence of 
symptoms of the disease was reported by 56.92% 
of the study subjects. The most commonly men-
tioned symptom was cough — 80.53% of respon-
dents; fewer patients reported expectoration of 
the sputum — 77.90%; and 59.16% of patients 
suffered form having dyspnoea — this symptom 
was considered as the most irritating by the lar-
gest group of patients (42.40%), the second being 
cough (32.87%). Symptoms occurred more frequ-
ently in men than in women, irrespective of smo-
king status (Table 2). During the previous year, 
COPD exacerbations (defined as the condition in 
when patients took antibiotics due to infection 
of the lower respiratory tract, or had to take oral 
glycocorticosteroids, or need emergency care, or 
hosptialization) were noted in 42.08% of patients, 
and hospitalisations caused by them — in 17.79%. 
Exacerbations and hospitalisations were more 
frequently reported by past smokers, irrespective 
of sex (Table 2).
The questionnaire took into account spirometric 
classification of COPD severity based on the 2010 
GOLD guidelines, whereas in a post hoc analysis, the 
severity of the disease was determined in accordance 
with the 2013 GOLD guidelines using data from the 
questionnaire concerning the degree of obturation 
(acc. to the 2010 GOLD guidlines) guidlines, severity 
of dyspnoe (using a modified MRC scale), and data 
on the prevalence of exacerbations from the year 
before the study.
In the study group, the majority were pa-
tients with moderate degree of the airway limi-
tation (2) — 55.38%, followed by mild degree 
(1) — 21.40%, then severe degree (3) — 19.96%, 
and the smallest group constituted the patients 
Table 1. Demographic data of the study group with respect to gender
Tabela 1. Dane demograficzne grupy badanej z podziałem według płci
Variable Whole group Men Women P W vs. M
Sex 
n (%)  
 
– 1947 (66.02) 1002 (33.98) –
Age  
mean ± SD
Me (Q25–Q75)
61.15 ± 10.25
61 (55–68)
61.59 ± 10.46
62 (55–70)
60.32 ± 9.80
60 (54–67)
0.0002
BMI  
mean ± SD
Me (Q25–Q75)
26.80 ± 3.74 
26.57 (24.49–28.73)
26.96 ± 3.51
26.87 (24.96–28.73)
26.47 ± 4.13
26.15 (23.53–28.84)
< 0.0001
Education  
N (%)
Primary 545 (19.4) 397 (21.56) 146 (15.27)
< 0.0001
Vocational 861 (30.64) 618 (33.57) 241 (25.21)
Secondary 916 (32.6) 551 (29.93) 359 (37.55)
Not completed higher/higher 488 (17.37) 275 (14.94) 210 (21.97)
Professional  
status  
N (%)
Working 1218 (42.53) 821 (43.76) 389 (39.94)
< 0.0001Not working 194 (6.77) 73 (3.89) 121 (12.42)
Pensioner/retiree 1452 (50.7) 982 (52.35) 464 (47.64)
Current smokers 
mean ± SD
Me (Q25–Q75)
Pack years 34.16 ± 19.03
30 (20–42)
36.57 ± 19.78
33.75 (24–45)
29.28 ± 16.40
28 (18–39)
< 0.0001
Number of cigarettes  
smoked/day
19.41 ± 8.4
20 (15–20)
20.24 ± 8.58
20 (15–20)
17.71 ± 7.74
20 (10–20) < 0.0001
Past smokers 
mean ± SD
Me (Q25–Q75)
Pack years 36.78 ± 22.35
31 (22–44.5)
40.32 ± 22.49
37.5 (26.6–47.5)
30.27 ± 20.69
26.3 (17.3–39)
< 0.0001
Had not smoked for (since 
the cessation)
9.26 ± 7.0
8 (5–11)
9.17 ± 6.97
8 (5–11)
9.43 ± 7.05
10 (5–12) 0.5446
M — men; W — women; SD — standard deviation; Me — median; BMI — body mass index; Q — quartiles
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Table 2. Asthma symptoms. exacerbations and hospitalizations
Tabela 2. Objawy astmy. zaostrzenia i hospitalizacje
Variable Total Women Men P W vs. 
M
Smokers Past  
smokers
P S vs. 
PastS
Number of days 
with symptoms 
n (%)
0–2 days 1246
(43.08)
462
(46.71)
772
(40.91)
0.0028 685
(42.15)
546
(44.00)
0.3234
3–7 days 1646
(56.92)
527
(53.29)
1115
(59.09)
940
(57.85)
695
(56.00)
Exacerbations 
n (%)
No 1471 
(49.88)
492
(49.45)
967
(49.90)
0.2002 818
(49.31)
641
(50.83)
< 0.0001
Yes 1241 
(42.08)
434
(43.62)
803
(41.43)
673
(40.57)
555
(44.01)
Not known 237 
(8.04)
69
(6.93)
168
(8.67)
168
(10.13)
65
(5.15)
Hospitalisations
n (%)
No 2268
 (77.27)
789
(79.62)
1465
(75.99)
0.0842 1300
(78.93)
947
(75.22)
< 0.0001
Yes 522 
(17.79)
159
(16.04)
361
(18.72)
236
(14.33)
280
(22.24)
Not known 145 
(4.94)
43
(4.34)
102
(5.29)
111
(6.74)
32
(2.54)
M — men; W — women; S  — smokers; PastS  — past smokers
with very severe degree (4) — 3.27%. Men com-
pared to women (P < 0.00001), and past smokers 
compared to current smokers (P < 0.00001) had 
more severe dyspnoe (Table 3). According to 
a new combined classification of COPD severity 
that was introduced in 2011 and is still used 
(2013 GOLD), the largest group consisted of 
patients with a  low symptom burden (mMRC) 
and a  low risk (A) — 52.67%, the second gro-
up in respect of size consisted of patients with 
a high symptom burden and a high risk (D) — 
20.45%, the third largest being patients with 
a  low symptom burden but a high risk (C) — 
16,16%, and finally those with a high symptom 
burden and a low risk (B) — 10.72% (Table 3).
In the study group, both classifications show 
considerable correlation (rs = 0.67, P < 0.001). 
While comparing men and women, men have 
significantly more severe course of the disease 
assessed by GOLD 2010 classification; using the 
GOLD 2013 classification, the difference is also 
unfavourable for men but it is not statistically 
significant. Taking into account smoking status, 
in both classifications past smokers demonstrated 
more severe course of COPD (Table 3).
The questionnaire also included questions 
concerning concomitant diseases at the time of the 
survey. Five diseases were listed most frequently: 
arterial hypertension (61.10% of respondents), 
diabetes (27.71%), gastric reflux (25.96%), neo-
plastic diseases (16.33%) and upper respiratory 
tract diseases (12.82%). Comparing women and 
men in respect of prevalence of the comorbidities, 
only hypertension was diagnosed significantly 
more frequently in men (P = 0.0178). Regarding 
smoking status, past smokers more frequently had 
arterial hypertension (P < 0.0001), diabetes (P < 
0.00001) and neoplastic diseases (P < 0.0442).
Doctors’ and patients’ opinions about  
the disease
The questionnaire included questions to the 
patients and doctors concerning the evaluation 
of the patients’ health condition. Most of the pa-
tients described their health condition as good 
(42.9%), whereas doctors more often described 
the health condition of their patients as moderate 
(46.18%). Although both evaluations are show by 
a considerable and significant correlation (rs = 
0.62, P < 0.01), the evaluation made by patients 
is significantly overstated compared to the evalu-
ation made by doctors (P < 0.001). The opinion of 
the patient about the health condition depended 
mainly on the degree of disease severity according 
to the 2013 GOLD classification (OR = 4.946; 
95% CI 3.468 — 7.054; P < 0.0001) and hospita-
lisations due to COPD exacerbations during the 
previous year (OR = 3.475; 95% CI 2.568 — 4.702; 
P < 0.0001), as well as on the used oxygen therapy 
(OR = 3.135; 95% CI 1.866 — 5.265; P < 0.001) 
and the age of the patient (OR = 1.679; 95% CI 
1.252 — 2.252; P = 0.001).
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The impact of the disease on the life  
of patients and their family life
The respondents were asked whether COPD 
influenced their life activities, family and social 
life, professional activities, hobby, sports activities 
and sexual life. The majority of patients answered 
positively. The respondents declared that COPD 
limited their sport activity (83.45% of patients), 
everyday life activities (82.78%) and family life 
(79.3%); a significant impact (considerable or gre-
at) was reported, apart from in sport (60.85%) and 
life activities (38.44%), in their professional life 
(34.9%), but the greatest influence, even leading 
to resignation from the activity, except for sport 
activity (21.75%), was reported for their sexual life 
(12.6%) and hobbies (11.49%) (Fig. 1).
While exploring factors that limit the pa-
tient’s activity in different fields, we took into 
consideration the following: age (≥ 65 years), 
sex, smoking status (past smoker), severity of the 
disease according to the 2013 GOLD classification 
(grade C/D), hospitalisations during the previous 
year, comorbidities (at least one chronic disease 
except for COPD), oxygen therapy (chronic or the 
necessity of its application) and the need for care 
from third parties.
Independent factors that significantly limit 
life activities (Fig. 2) were: age ≥ 65 (OR = 1.566; 
CI 95% 1.169–2.096; P = 0.003), more severe 
grades of COPD with a high risk of health compli-
cations (C/D) (OR = 2.362; CI 95% 1.729–3.227; 
P < 0.0001), the occurrence of comorbidities (OR 
= 1.317; CI 95% 1.014–1.711; p = 0.039) and 
the necessity for care from third parties (OR = 
3.350; CI 95% 2.002–5.605; P < 0.0001). 3.18% 
of respondents needed permanent care by third 
parties, and 17.28% needed temporary care.
The factors that negatively influence family 
life of COPD patients were: age ≥ 65 (OR = 1.817; 
CI 95% 1.372–2.407; P < 0.0001), COPD severi-
ty (C/D) (OR = 2.197; CI 95% 1.655–2.917; P < 
0.0001), concomitant diseases (OR = 1.353; CI 
95% 1.054–1.736; P = 0.018) and the necessity 
for care from third parties (OR = 3.886; CI 95% 
2.408–6.272; P < 0.0001). The status of a past 
smoker was a positive factor (OR = 0.667; CI 95% 
0.525–0.847; P = 0.001) (Fig. 3).
The patient usually explained the negative 
impact of COPD on family life in terms of finan-
cial aspects (40.05%), nuisance for the family 
(34.46%), the disease focusing the attention of 
the whole family (10.56%), and the limited role 
of the patient in the family (21.92%).
Independent factors that impair professio-
nal activity of COPD patients were: more severe 
grades of COPD (C/D) (OR = 2.045; CI 95% 1.309 
= 3.194; p = 0.002) and concomitant diseases 
(OR = 1.507; CI 95% 1.081–2.101; p = 0.015). 
Table 3. The severity of COPD by gender and smoking status according to the GOLD classification of 2010 and 2013 GOLD
Tabela 3. Ciężkość POChP z uwzględnieniem płci i statusu palenia według klasyfikacji GOLD 2010 i GOLD 2013
Degree Total Men Women P W vs. 
M
Smokers Past smokers P S vs. 
PastS
GOLD 2010 n (%)
I 609
(21.40)
370
(19.92)
236
(24.25)
< 0.0001
407
(25.47)
196
(16.08)
< 0.0001
II 1576
(55.38)
994
(53.53)
572
(58.79)
890
(55.69)
672
(55.13)
III 568
(19.96)
424
(22.83)
142
(14.59)
263
(16.46)
299
(24.53)
IV 93
(3.27)
69
(3.72)
23
(2.36)
38
(2.38)
52
(4.27)
GOLD 2013 n (%)
A 1499
(52.67)
953
(51.32)
535
(54.98)
0.0692
935
(58.51)
555
(45.53)
< 0.0001
B 305
(10.72)
193
(10.39)
111
(11.41)
153
(9.57)
148
(12.14)
C 460
(16.16)
306
(16.48)
152
(15.62)
250
(15.64)
203
(16.65)
D 582
(20.45)
405
(21.81)
175
(17.99)
260
(16.27)
313
(25.68)
M — men; W — women; S  — smokers; PastS  — past smokers; GOLD — Global Initiative for Lung Diseases
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Figure 1. The impact of chronic obstructive pulmonary disease on the lives of patients and their families, in the patients opinion 
Rycina 1. Wpływ przewlekłej obturacyjnej choroby płuc na życie chorego i jego rodziny w opinii pacjenta
Figure 2. Factors limiting the life activity of patients suffering from 
chronic obstructive pulmonary disease 
Rycina 2. Czynniki ograniczające aktywność życiową u chorych na 
przewlekłą obturacyjną chorobę płuc
Figure 3. Factors adversely affecting the family life of patients suffe-
ring from chronic obstructive pulmonary disease 
Rycina 3. Czynniki negatywnie wpływające na życie rodzinne u cho-
rych na przewlekłą obturacyjną chorobę płuc
The status of past smoker had a positive impact (OR 
= 0.687; CI 95% 0.482–0.978; p = 0.037) (Fig. 4).
Due to COPD, 39.13% of patients did not 
work at all or just for some time during the pre-
vious year, 8.09% of them were entitled to pension 
due to COPD, and 31.04% of patients were on sick 
leave 21.34 ± 21.78 days on average.
A negative influence on the patient’s social life 
was due to: more severe grade of the disease (C/D) 
(OR = 1.807; CI 95% 1.425–2.293; P < 0.0001) and 
the necessity for care by third parties (OR = 2.812; 
CI 95% 2.009–3.936; P < 0.0001) (Fig. 5).
An independent factor that limited sports ac-
tivities in COPD patients was COPD severity (C/D) 
(OR = 1.540; CI 95% 1.194–1.986; P = 0.001), and 
the status of past smoker was a positive factor (OR 
= 0.752 ; CI 95% 0.592–0.954; P = 0.019) (Fig. 6).
Independent factors that interfered with 
the patient’s hobbies were as follows: age ≥ 65 
(OR = 1.291; CI 95% 1.027–1.623; P = 0.028), 
Figure 4. Factors affecting proffesional activity of patients suffering 
from chronic obstructive pulmonary disease 
Rycina 4. Czynniki wpływające na aktywność zawodową u chorych 
na przewlekłą obturacyjną chorobę płuc
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Figure 5. Factors adversely affecting the social life of patients suffe-
ring from chronic obstructive pulmonary disease 
Rycina 5. Czynniki negatywnie wpływające na życie towarzyskie 
chorych na przewlekłą obturacyjną chorobę płuc
severe stage of the disease (C/D) (OR = 1.876; CI 
95% 1.494–2.356; P < 0.0001) and the necessity 
for care from third parties (OR = 1.291; CI 95% 
0.971–1.717; P = 0.079), but the last parameter 
was not statistically significant. The status of past 
smoker had a positive effect (OR = 0.764; CI 95% 
0.621–0.940; P = 0.011) (Fig. 7).
An independent factor that impaired sexual 
life in COPD patients was C/D grade of COPD (OR 
= 1.655; CI 95% 1.343–2.039; P < 0.0001). The 
use of, or the necessity of using, oxygen therapy 
also increased the risk of limitations, but it was 
not statistically significant, taking into account 
the assumed significance threshold (OR = 1.808; 
CI 95% 0.933–3.501; P = 0.075) (Fig. 8).
75.45 % of respondents declared that their family 
supported them in their coping with the disease.
History of tobacco smoking
56.73% of the survey participants were cur-
rent smokers, and 43.37% of them declared that 
they had stopped smoking. Most current smokers 
Figure 6. Factors affecting the sporting activity of patients suffering 
from chronic obstructive pulmonary disease 
Rycina 6. Czynniki wpływające na uprawianie sportu przez chorych na 
przewlekłą obturacyjną chorobę płuc
Figure 7. Factors limiting the hobbies of patients suffering from chro-
nic obstructive pulmonary disease 
Rycina 7. Czynniki ograniczające chorym na przewlekłą obturacyjną 
chorobę płuc zajmowanie się hobby
(99.38%) smoked cigarettes, 0.65% of them smo-
ked cigars and 1.51% smoked pipes. For nearly all 
of them (98.79%), doctors had previously recom-
mended smoking cessation. 54.03% of current 
smokers had made attempts to quit smoking. The 
mean number of attempts to quit smoking in this 
group was 4.05 ± 3.14, and it was significantly 
higher (P < 0.00001) compared to the group of 
past smokers at 3.17 ± 2.61 attempts. The mean 
time that passed from smoking cessation in the 
group of past smokers was 9.26 ± 7 years. Cu-
rrent smokers had a longer history of smoking 
(P = 0.0179), but they had a smaller number of 
cigarettes smoked daily and slightly less pack 
years (P = 0.00001 for both groups) (Table 4).
As the main reason for cigarette smoking, 
the respondents gave the following: addiction 
— 28.44%, pleasure — 23.34%, habit — 17.78%, 
stress relief — 13.20% and smoking friends — 
2.74%. 3.03% of respondents mentioned a smo-
king family member as the main reason for ciga-
rette smoking, and 1.48% said body mass control.
Figure 8. Factors limiting the sexual life of patients suffering from 
chronic obstructive pulmonary disease
Rycina 8. Czynniki ograniczające życie intymne chorych na przewlekłą 
obturacyjną chorobę płuc
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The impact of smoking on family life  
and the reaction of the family to addiction
According to the patients, tobacco smoking 
had the most negative impact on their health 
(52.65%) and family budget (41.83%). 16.38% of 
patients declared a negative impact of tobacco 
smoking on relations within the family.
Among current smokers, 69.62% of respon-
dents declared a willingness to quit smoking 
(definitely yes — 13.38%, I think yes — 56.24%), 
the motivation for their decision was health re-
Table 4. Comparison of smokers and ex-smokers in terms of smoking load
Tabela 4. Porównanie palących i byłych palaczy pod względem obciążenia paleniem tytoniu
Variable Current smokers PastS S vs. PastS  
Smoking status n (%) 1665 (56.73) 1270 (43.27) –
The number of attempts to quit smoking 4.05 ± 3.14
3 (2–5)
3.17 ± 2.61
3 (2–4)
< 0.00001
Duration of smoking  
mean ± SD
Me (Q25–Q75)
34.84 ± 10.81
35 (30–40)
32.32 ± 10.76
31 (25–40)
0.0179
Duration of not smoking the time since smoking cessation  
mean ± SD
Me (Q25–Q75)
– 9.26 ± 7
8 (5–11)
–
Average number of cigarettes/day  
mean ± SD
Me (Q25–Q75)
19.41 ± 8.4
20 (15–20)
21.93 ± 9.56
20 (20–21)
< 0.00001
Average number of pack  
mean ± SD
Me (Q25–Q75)
34.16 ± 19.03
30 (20–42)
36.78 ± 22.35
31 (22–44.5)
< 0.00001
SD — standard deviation; Me — median; S — smokers; PastS — past smokers; Q — quartiles
Figure 9. The effect of smoking on various aspects of the patient’s life
Rycina 9. Wpływ palenia tytoniu na różne aspekty życia pacjenta
asons (diagnosis of COPD — 35.06%, effect on 
health — 26.58%), financial reasons (19.74%) and 
insistence of the family (11.02%).
Simultaneously, 71.79% of patients declared 
that they received support from their family (defi-
nitely yes — 24.98%, I think yes — 46.81%) in their 
struggle with addiction. 54.03% of currently smo-
king patients had made attempts to quit smoking 
with no permanent effect. Unsuccessful attempts 
to quit smoking were caused mainly by the force of 
habit — 25.08%, but 5.78% of respondents mentio-
ned smoking family members as the main reason
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Among the factors that favour successful smo-
king cessation, the most important are age ≥ 65 years 
and more severe obturation (2010 GOLD stage III/IV).
Discussion
Chronic obstructive pulmonary disease is 
a progressing disease; in the beginning it is latent, 
but consequently it leads to irreversible con-
sequences, and in some patients, to respiratory 
disability and even to premature death [3]. 
Figure 10. The declared reasons for the desire to quit smoking
Rycina 10. Deklarowane powody chęci rzucenia palenia
Figure 11. Reasons for unsuccessful attempts to quit smoking
Rycina 11. Powody nieudanych prób rzucenia palenia
More than 10,000 COPD patients treated by 
general practitioners and specialists participated 
in the present study. To the best of the authors’ 
knowledge, it is the largest published epidemio-
logical study apart from the National Program 
of Early Detection and Prevention of COPD (ad-
dressed to a different group) [10], conducted in 
Poland and describing this group of patients in 
such a detailed manner. The KOMPAS study [11] 
was a prospective study, but it was conducted on 
a smaller group of COPD patients (3315 patients).
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Both studies showed that men more often 
suffer from COPD (in the present paper — 66.02%, 
in the KOMPAS study [11] — 69.3%), which is 
in accordance with the results of epidemiological 
studies conducted on the general population, 
which also showed higher morbidity rates among 
men in Poland [4, 12].
The mean age of patients in the present study 
was 61.15 years. In the most similar study in re-
spect of cohort selection, the KOMPAS study, the 
age of patients was comparable (62.9 years) [11]. 
The disease usually affects people between 45 and 
70 years of age, cases of COPD in patients under 
40 years of age are relatively rare. However, it 
should be emphasised that advanced age is a risk 
factor for the disease, which, on the one hand may 
be connected with pathophysiological processes 
that are observed in an ageing organism, and on 
the other hand might be the result of the sum of 
harmful exposures to various harmful factors. 
It is true that the prevalence of COPD increases 
in ageing societies [3]. 
The proportion of currently smoking patients 
in the present paper was 56.73%, in the KOMPAS 
study [11] it was only 32%, but in the National 
Program of Early Detection and Prevention of 
COPD it was as much as 61.6% [10]. The last 
two projects also included people who declared 
themselves to be never smokers. In all programs, 
smoking status was assessed exclusively based 
on the declaration of the patients, without veri-
fication with objective methods, which does not 
ensure reliable results. In the National Program 
of Early Detection and Prevention of COPD [10], 
participants were inquired by another doctor, 
which could persuade more persons to confess 
that they still smoked cigarettes. Furthermore, 
this project could be entered by anyone who 
wanted to examine lung function, whereas the 
present study and the KOMPAS study [11] inc-
luded people with previous diagnosed disease 
(patients under the care of doctors filling the 
questionary); therefore, these values cannot be 
directly compared.
A  significant element in management of 
COPD patients is the disease severity. The dise-
ase severity influences the patient’s prognosis, 
quality of life and limitations of life activities, 
but it is also important for family relations and 
the necessity for care from third parties. 
The study was designed in 2011; therefore, 
severity was assessed based on the airway limi-
tation according to current 2010 GOLD classifi-
cations [3]. According to this grading, the group 
with the worst prognosis were men they were past 
smokers, who were also more exposed to tobacco 
(the mean number of pack years of men and of 
past smokers was significantly higher, compared 
to women and current smokers). Similar relations 
were obtained in the KOMPAS study [11].
In the GOLD report [3] published at the end 
of 2011, a new scale of the evaluation of COPD 
severity was proposed. Except for obturation, 
it took into account symptoms severity and 
annual prevalence of exacerbations. Using the 
data included in the questionnaire, the post hoc 
analysis in accordance with new guidelines was 
carried out. The largest group of patients con-
stituted the patients from category A  (52.67%) 
with a low risk and a low symptom burden, but 
the second category consisted of patients from 
group D (20.45%), with a high symptom burden 
and a high risk (Table 3). There are only a  few 
international publications showing distribution 
of COPD severity according to new guidelines, 
and to the best of the authors’ knowledge, this is 
the only Polish study conducted on such a large 
group of patients. Johannessen et al. conducted 
a classification according to new guidelines on 
a cohort of approximately one thousand patients 
from the GenKOLS study [13]. Group A included 
20% of patients, B — 30%, C — 6% and D — 
44%. The limitation of the cohort was the fact 
that it recruited patients with FEV1 below 80% 
of predicted value, so it excluded patients with 
a mild degree of obturation, which made the 
proportion of patients in groups A and B smaller, 
and consequently made the proportion of patients 
in groups C and D bigger. Jones et al. [14] also 
classified patients according to the 2011 GOLD. 
The cohort from the Adelphi Respiratory Disease 
Specific Programme, similarly as in the previous 
study, consisted of approximately 1000 patients 
recruited during routine visits (38.5% primary 
Figure 12. Risk factors for effective cessation
Rycina 12. Czynniki ryzyka skutecznego zerwania z nałogiem
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care clinic). 80% of participants of that study 
be longed to class 1 or 2, according to the 2010 
GOLD classification, which is similar to the cha-
racteristics of the group from the presented study 
(in total 76%), although they were on average 
3 years older (64.9 years). In the study by Jones, 
the distribution of severity according to the 2011 
GOLD with the use of CAT test was the following: 
group A — 9.3% of patients, group B — 48.5%, 
group C — 0.7% and group D — 41.5%, but when 
the mMRC scale was used, the distribution chan-
ged in the following way: category A — 37.8%, 
category B — 20.1%, category C — 13.4% and 
category D — 28.8%. In the new classification, 
the shift of patients towards category D with 
a high risk in comparison to not numerous grade 
IV from the previous classification is caused by 
recurrent exacerbations (≥ 2/year) in a significant 
proportion of respondents (in this way 80% pa-
tients were classified to groups D or C). But in the 
two quoted studies there is a higher proportion 
of patients from groups B or D in relation to the 
present study, which results from more severe 
symptoms (in the present study A+C/B+D — 
69%/31% vs. Johannessen [13] 26%/74% vs. Jones 
[14] 10%/90% for CAT and 51%/49% for mMRC). 
It is possible that the differences also result from 
the intensity of treatment; the quoted studies do 
not contain data about the used therapy. 
However, if we compare the groups with 
a  low (A+B) and a  high risk (C+D) between 
the studies, the differences are not so great (the 
present study A+B/C+D — 63%/37% vs. Johan-
nessen [13] 50%/50% vs. Jones [14] 58%/42% for 
CAT and mMRC). 
The data from the study were analysed paying 
special attention to the impact of COPD and to-
bacco smoking on the patient’ and their family 
life. We lack such data for the Polish population, 
and those in the international literature are scarce 
and fragmentary.
In the present study, disease severity clas-
sified as C or D according to the 2013 GOLD [3] 
significantly impaired all evaluated aspects of the 
patient’s  life. At the beginning of COPD of the 
disease, clinical symptoms are usually latent, and 
the patient does not notice them or does not take 
them seriously because they do not limit at all or 
only little various aspects of life, including family 
life. The problem arises when clinical symptoms 
occur frequently and are so intensive that they 
impair the patient’s  life, personal professional 
activities, interests, hobbies, and sports, and 
when they influence the patient’s family life in 
its various aspects: from the financial burden to 
temporary or permanent disability to work, drug 
expenses and sexual life. The impact of the dise-
ase on so many aspects of the patient’s life causes 
a  significant burden for the patients and their 
families. The majority (nearly 80%) of patients 
report that, in their opinion, the disease impared 
their family life in various ways. 
Others independent factors that influence the 
patient’s activities are age ≥ 65 years, concomitant 
diseases and care from third parties. It should 
be emphasised that the first two factors correlate 
positively with the severity, but the necessity for 
care from third parties is a consequence of severe 
genaral condition including severe degree of the 
disease, comorbidities and age.
Uzaslan et al. [15] also explored the impact of 
the disease on the patient’s life among the inha-
bitants of the Middle East, North Africa and Paki-
stan. The impact of the disease on sports activities 
was declared by 57.1% of patients (40.9–80%) vs. 
60.85% of Polish patients, the impact on family 
life — 31.7% (19.1–54.9%) vs. 29.79%, on sexual 
life 37.5% (19–54.9%) vs. 34.28% and on social 
life 37.5% (22.7–54%) vs. 26.52%.
In patients’ everyday struggle with the di-
sease, family is important. Lack of support is 
related with psychological problems, severity 
of dyspnoe and poor quality of life [16]. In the 
study group, 75.45% of patients declared that 
they received support from their family. On the 
other hand, as many as 24.55% of patients had 
greater risk of depression and neuroses and the 
risk of worse results of therapy due to lack of 
support [16, 17]. The occurrence of COPD in 
a spouse also increases the risk of depression and 
neurosis [17].
COPD is a  tobacco dependent disease, 
and this correlation is very strong; therefore, 
smoking cessation may reduce the risk of the 
disease or at least slow its progression. Although 
tobacco smoking is generally considered to be 
harmful to health, it is still popular in Poland, 
which means an increasing number of patients 
suffering from tobacco dependent diseases, 
including COPD.
Early diagnosis of airway obturation that 
is the pathophysiological mechanism of COPD, 
together with minimal intervention, favours an 
succesful strungle against addiction [18]. Accor-
ding to the epidemiological study conducted by 
Anna Elgalal et al. in the years 1998–2000 in the 
region of Łódź, between 36.4% (in the city centre) 
and 85.0% (in the countryside) of COPD patients 
were not diagnosed correctly, and consequently 
they were not correctly treated or educated [12].
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Smoking cessation is the only known effecti-
ve method of stopping COPD progression. When 
addition to nicotine is diagnosed, it is recommen-
ded to conduct so-called minimal intervention 
(5-step guidelines: ASK about tobacco use at every 
visit, ADVISE to quit, ASSESS willingness to at-
tempt to quit, ASSIST with developing a quitting 
plan and ARRANGE a follow-up contact) [3]. Such 
intervention together with spirometry is effective 
in 10–11% per year of Polish patients with airway 
limitation [19, 20]. However, doctors rarely con-
duct a minimal intervention during routine visits. 
Although it is considered that support from 
the family is crucial for efficacy of smoking ces-
sation, there are no studies of the role of family 
in the process. 
Patients admit that insistence of the family 
to quit smoking is a motivating factor. They are 
conscious that smoking may influence relations 
within the family, family budget and have an 
impact on their sexual life. It was confirmed in 
several studies that men with COPD very often 
have erectile dysfunction [21].
An independent factor that favoured succe-
sful smoking cessation in the present study was 
COPD severity measured by airway limitation. 
A similar observation was made by Bednarek et 
al. [22], who showed that the more severe dise-
ase, the greater the chance of permanent smoking 
cessation.
Negative relations in the family should also 
be taken into consideration. Some patients re-
turn to their addiction due to smoking family 
members.
The present study allowed to gather the 
key data concerning the impact of the disease 
and nicotine addiction on the patient’s and his/ 
/her family life. We analysed information about  fac-
tors that influence tobacco smoking and support/ 
/impair the struggle against addiction. 
The results of the present study may help in 
preparing of an educational program that could 
improve patients’ knowledge about the disease. 
Furthermore, they could prepare doctors and pa-
tients for the struggle against tobacco addiction, 
they could strengthen the role of the family in the 
management of patients with chornic diseases, 
and improve cooperation between the doctor 
and patient.
Apart from previously defined objectives of 
the study, its additional benefit was improvement 
of relation doctor-patient, based on confidence to 
each other, understanding of the patient’s pro-
blems, willingness to join forces in order to im-
prove the patient’s health. According to the GOLD 
[3], cooperation doctor-patient is a key element in 
COPD management. In patients with more severe 
stage of COPD, the role of the family is of crucial 
importance as the burden of care of the patient 
rests on its shoulders. Therefore, the program 
also paid attention to this aspect of management 
of COPD patients.
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